Tessera gets up to $50M from the Gates Foun­da­tion; Tvar­di’s re­verse merg­er

Plus, news about Sen­so­ri­on, Soleno Ther­a­peu­tics, Corvus and Hansa Bio­phar­ma:

Tessera Ther­a­peu­tics bags up to $50M for sick­le cell dis­ease R&D: The in­vest­ment is part …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER